ISCGX Mutual Fund

ISCGX Mutual Fund

NAV$4.98
See how much of ISCGX you already own
Just $25 once·$99/mo·Download sample
X-ray my portfolio free

Fund Essentials - as of Sep 30, 2026

Net Assets
$2M
Expense Ratio
1.10%
Dividend Yield (Current)
-
Holdings
58
Inception Date
Aug 31, 2012
Fund Family
Transamerica
Investment Style
PRO
Asset Class
PRO
Legal Structure
PRO
Dividend Frequency
Annually
SEC 30-Day Yield
PRO

Performance

YTD+0.78%
1 Year+0.21%
3 Year+7.16%
5 Year-3.43%
10 Year+7.54%

Asset Allocation

Stocks: 100.00%
See how much of ISCGX you already own
Your funds unpacked, overlap, fees and score, free on screen. The full report comes with FundXLS. Download sample.
X-ray my portfolio free

Top Holdings

View All →
TickerNameWeight
LGNDLigand Pharmaceuticals, Inc.4.84%
PDFSPdf Solutions Inc3.11%
OIIOceaneering International Inc2.95%
ULSUl Solutions Inc2.75%
STVNStevanato Group Spa2.60%
Top 10 Concentration: 28.42%Report Date: Sep 30, 2026
Download all 58 holdings for ISCGX
CSV export with sector, industry & share changes
Get CSV

Dividend Summary

View Details →
Frequency
Annually
Latest Distribution
$0.67
-

Peer Comparison

Benchmark
PRO
Peer outperformance: PRO
Category rank: PRO
This Mutual Fund
PRO
Peer Avg
PRO

ISCGX Mutual Fund Overview

ISCGX Mutual Fund (Transamerica Small Cap Growth Fund Class I) is managed by Transamerica with $2.1M in net assets. ISCGX expense ratio is 1.10%, holding 58 positions across sectors including Health Care, Industrials, Information Technology. Inception date: 2012-08-31.

ISCGX performance shows a YTD return of 0.78%. The 1-year return is 0.21% and the 5-year return is -3.43%.

ISCGX top holdings include Ligand Pharmaceuticals, Inc. (4.8%), Pdf Solutions Inc (3.1%), Oceaneering International Inc (3.0%), Ul Solutions Inc (2.8%), Stevanato Group Spa (2.6%). Go to all ISCGX holdings, ISCGX sectors, or ISCGX dividends.

ISCGX can be compared against other funds. Use ISCGX overlap to find shared positions, or ISCGX vs another fund for a side-by-side view. ISCGX alternatives are available via the screener, along with tax-loss harvesting opportunities.